Marathon Partners Equity Management’s Henry Schein HSIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$921K Sell
12,500
-35,000
-74% -$2.7M 1.04% 13
2025
Q4
$3.59M Sell
47,500
-30,000
-39% -$2.11M 3.57% 8
2025
Q3
$5.14M Sell
77,500
-32,500
-30% -$2.25M 3.7% 7
2025
Q2
$8.04M Buy
110,000
+2,500
+2% +$172K 6.98% 6
2025
Q1
$7.36M Buy
107,500
+20,000
+23% +$1.48M 7.54% 5
2024
Q4
$6.05M Buy
+87,500
New +$6.28M 5.26% 7

Other funds holding HSIC

Marathon Partners Equity Management's HSIC Position: Q1 2026 in Review

Marathon Partners Equity Management reduced its Henry Schein (HSIC) stake by 74% in Q1 2026, selling an estimated $2.7M and leaving 12,500 shares worth $921K. The position accounts for 1.04% of the portfolio, ranked #13.

Marathon Partners Equity Management first reported a position in HSIC in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.04M in Q2 2025. 557 funds tracked by Wall St. Rank hold HSIC as of Q1 2026.

  • Marathon Partners Equity Management held 12,500 shares of Henry Schein worth $921K as of Q1 2026.
  • Marathon Partners Equity Management sold 35,000 Henry Schein shares in Q1 2026, an estimated $2.7M.
  • Henry Schein made up 1.04% of Marathon Partners Equity Management's portfolio in Q1 2026, its #13 holding.
  • Marathon Partners Equity Management first reported a position in Henry Schein in Q4 2024 and has held it in 6 quarters since.
  • Marathon Partners Equity Management's Henry Schein position peaked at $8.04M in Q2 2025.
  • 557 funds tracked by Wall St. Rank held Henry Schein as of Q1 2026.

Based on Marathon Partners Equity Management's 13F filing for Q1 2026, filed 15 May 2026.